Join Our Immuno-Oncology Research Team
The Medical Immuno-Oncology Research Group (MIORG) at the University of Turku is leading innovative research into cancer treatments. We are excited to offer a doctoral researcher position within the ImmuDocs Doctoral Education Pilot, aimed at advancing therapies for “cold tumors” resistant to current treatments.
Project Title: Exploring a Novel Immunoproteasome Activation Factor to Enhance Cross-Presentation and Responses to Anti-PD1 Blockade in Cold Tumors.
Principal Supervisor: Adj. Professor Carlos Rogerio Figueiredo, Institute of Biomedicine, University of Turku (crdefi@utu.fi).
Collaboration Highlight: MD Anderson Cancer Centre, University of Texas, USA.
About the Project
This project focuses on understanding and improving the immune system’s ability to combat cancer. You will:
- Study the role of dendritic cells in initiating the body’s defense against tumors.
- Investigate how a newly identified immune factor can activate the immunoproteasome, enhancing the immune system’s ability to recognize and attack cancer cells.
- Develop strategies to improve the effectiveness of existing immunotherapies, such as anti-PD-1 blockade, in treating metastatic melanoma.
Why Join Us?
- Cutting-Edge Research: Your work will contribute directly to the development of new treatments for cancer.
- Expert Collaboration: Engage with top researchers like Professor Menashe Bar-Eli and a dedicated team pushing the boundaries of immunotherapy.
- Professional Growth: The ImmuDocs program is designed to support your career development, offering opportunities in research, academia, and the healthcare industry.
- Fully Funded Position: Full support for project development, making the best use of core facilities at Turku Bioscience Center, Institute of Biomedicine and MIORG.
Candidate Profile:
- Possesses a relevant higher university degree or is in the final stages, qualifying for a doctoral degree by June/July 2025.
- Has a strong interest in immunology and oncology research.
- Is motivated to tackle challenging research questions with significant clinical implications.
Application Information:
- Application Period for Spring: April 3–22, 2024
- Start Date: August 1, 2024
- Eligibility: Must not have been granted doctoral study rights before November 1, 2023.
Learn more about our research and how to apply: Visit Medical Immuno-Oncology Research Group (MIORG).
Embark on a fulfilling journey with us, contributing to significant advancements in immunology and cancer therapy. Apply now and become a key player in transforming medical science!
For Postdocs
We are always happy to hear from postdoctoral researchers who would like to begin, or continue, their research career in ocular oncology, please send your CV and a brief description of your area of interest to crdefi@utu.fi.